ReviewGenes & diseases2026
Non-clinical safety considerations on genome editing using the CRISPR/Cas system.
Parto Toofan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewGenes & diseases2026
Parto Toofan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.